Medications for Breast Cancer, Adjuvant
What is Breast Cancer, Adjuvant:
Adjuvant therapy for breast cancer is any treatment given after primary treatment to increase the chance of long-term survival. This may can include chemotherapy, radiotherapy or hormonal therapy.
Medications to treat Breast Cancer, Adjuvant
The following list of medications are in some way related to, or
used in the treatment of this condition.
|
Drug name
|
Rx / OTC
|
Preg
|
CSA
|
Alcohol |
Reviews
|
Rating
|
Popularity
|
|
Femara
|
Rx
|
D
|
N
|
|
7 reviews
|
7.0
|
|
|
Generic name: letrozole systemic
Drug class:
hormones/antineoplastics,
aromatase inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
tamoxifen
|
Rx
|
D
|
N
|
|
3 reviews
|
8.0
|
|
|
Generic name: tamoxifen systemic
Brand name:
Soltamox
Drug class:
hormones/antineoplastics,
selective estrogen receptor modulators
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
Herceptin
|
Rx
|
D
|
N
|
|
2 reviews
|
9.0
|
|
|
Generic name: trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
letrozole
|
Rx
|
D
|
N
|
|
11 reviews
|
5.0
|
|
|
Generic name: letrozole systemic
Brand name:
Femara
Drug class:
hormones/antineoplastics,
aromatase inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
Taxol
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: paclitaxel systemic
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
Lupron
Off Label
|
Rx
|
X
|
N
|
|
1 review
|
2.0
|
|
|
Generic name: leuprolide systemic
Drug class:
hormones/antineoplastics,
gonadotropin releasing hormones
For consumers:
dosage,
interactions,
side effects
Off Label:
Yes
|
| |
|
Soltamox
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: tamoxifen systemic
Drug class:
hormones/antineoplastics,
selective estrogen receptor modulators
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
epirubicin
|
Rx
|
D
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: epirubicin systemic
Brand names:
Ellence,
Pharmorubicin PFS
Drug class:
antibiotics/antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
leuprolide
Off Label
|
Rx
|
X
|
N
|
|
1 review
|
2.0
|
|
|
Generic name: leuprolide systemic
Brand name:
Lupron
Drug class:
hormones/antineoplastics,
gonadotropin releasing hormones
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
Onxol
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: paclitaxel systemic
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
paclitaxel
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: paclitaxel systemic
Brand names:
Taxol,
Onxol
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
trastuzumab
|
Rx
|
D
|
N
|
|
2 reviews
|
9.0
|
|
|
Generic name: trastuzumab systemic
Brand name:
Herceptin
Drug class:
HER2 inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph
|
| |
|
Ellence
|
Rx
|
D
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: epirubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
Pharmorubicin PFS
|
Rx
|
D
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: epirubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage,
interactions,
side effects
|
| |
Learn more about Breast Cancer, Adjuvant
Micromedex® Care Notes
Symptom checker
Drugs.com Health Center
Legend
| Off Label |
This medication may not be approved by the FDA for the treatment of this condition. |
| Prescription Only / Over the Counter |
| Rx |
Prescription Only |
| OTC |
Over the Counter |
| Rx/OTC |
Prescription or Over the Counter |
| Pregnancy |
| A |
Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B |
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C |
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D |
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X |
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N |
FDA has not classified the drug. |
| Controlled Substances Act Schedule |
| N |
Is not subject to the Controlled Substances Act. |
| 1 |
Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 |
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 |
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 |
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 |
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol |
| X |
Interacts with Alcohol. |
Browse Drugs by Condition
